|

rabbit ATG Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: thymoglobulin

Pipeline

Phase 2: 2

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1
  • Children's Hospital Medical Center, Cincinnati1

Indications

  • Cancer2
  • Severe Marrow Failure1
  • Fanconi Anemia1
  • Thalassemia1
  • Thalassemia, Beta1

Basking Ridge, New Jersey1 trial

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Memorial Sloan Kettering at Basking Ridge (Consent only)

Phase 2

New York, New York1 trial

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Memorial Sloan Kettering Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.